Relafen 750, pharmacologically known as diclofenac potassium, presents a compelling case from a biochemical point of view . Its effect primarily involves the inhibition of cyclooxygenase catalysts , specifically COX-2, resulting in a decrease in prostaglandin formation. This process effectively alleviates soreness and swelling associated with infla